INTRODUCTION
Infection with antimicrobial resistant (AMR) pathogens is associated with high morbidity and mortality for patients and a significant economic burden on health systems [1, 2] . In sub-Saharan Africa (sSA), the prevalence of AMR in key pathogens, is amongst the highest in the world [3] and the mortality burden from drug-resistant infections is predicted to be huge [4] . Interventions which reduce excessive antimicrobial usage (AMU) have been shown to reduce AMR [5] and optimization of AMU is a key WHO target. However, antimicrobial stewardship (AMS) programs are typically tailored to high-income settings, frequently incorporating specialist infection liaison services, advanced microbiological diagnostics and a restrictive antibiotic formulary [5, 6] . Few hospitals in sSA have AMS programs in place [7] and a better understanding of the ideal components of an effective and acceptable AMS intervention in a resource-limited setting is needed.
Ceftriaxone, a parenteral third-generation cephalosporin (3GC), has long been the antibiotic of choice in many sub-Saharan African hospitals, its once daily dosing regimen and broad-spectrum of activity, making it a useful and convenient choice in settings where diagnostics and nursing capacity are limited [8, 9] . In sSA the prevalence of 3GC resistance amongst key bloodstream pathogens is high [10] and widespread reliance on ceftriaxone has likely been a major driver of this class-level resistance [11] [12] [13] .
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In Malawi, sentinel surveillance from patients presenting to Queen Elizabeth Central Hospital (QECH) in Blantyre has demonstrated a rapid rise in 3GC-R amongst bloodstream Enterobacterales, occurring contemporaneously with the widespread roll-out of ceftriaxone [14] . Limited availability of alternatives antibiotics, means that reducing class-level resistance to cephalosporins and preventing further AMR transmission, is of critical importance. AMS is a key strategy for achieving this [15] , yet little is known about antibiotic prescribing practices at QECH, or what constitute deliverable, acceptable and sustainable interventions and targets for an AMS program in a resource-poor hospital.
The aim of this work was to establish and evaluate a formal AMS program on the adult medical wards at QECH. We conceived and introduced a locally appropriate antibiotic guideline and evaluated its impact on ceftriaxone usage and cost of antibiotic provision. Incorporating qualitative methodology, we additionally aimed to understand the barriers to and enablers of our stewardship approach.
METHODS

Setting
Malawi is a low-income country with low healthcare expenditure (~3% GDP) [16] .
QECH is a 1300 bed unit and the only hospital providing free inpatient care in Blantyre. There are 200 adult medical beds, and ~70% of adult inpatients are HIV-7 infected [17] . Quality assured blood culture and cerebrospinal fluid analysis are provided by the Malawi-Liverpool Wellcome Trust Clinical Research Programme (MLW), but there is no formal microbiology liaison service. Prior to this study, there were no formal AMS activities and no specific antibiotic guideline.
Study design
Overview
The stewardship program had three phases: a pre-implementation prescribing survey, designed to identify stewardship targets (January 2016); implementation of an antibiotic guideline (June 2016) and two post-implementation prescribing surveys (January 2017, January 2018). Point-prevalence surveys (PPS) with feedback to prescribers began at the start of the implementation phase and continued for 28months. The study methods are described below and in more detail in the Supplementary Material.
Antibiotic prescribing surveys
Inpatient records were reviewed to collect data on key stewardship quality indicators.
The pre-implementation survey was carried out by RL, DK and AK. RL then then drafted the antibiotic guideline. Post-implementation surveys were carried out by a doctor who was not involved in the implementation phase (KH). We adapted standardized stewardship quality indicators to suit local practice [18] , focusing on measurable targets such as 48-hour antibiotic review and duration of antibiotic prescription (Supplementary Methods, Table 1 ).
Stewardship intervention
A series of multidisciplinary team meetings were held to establish the AMS program, convening clinicians, nursing managers, hospital directorship, pharmacists and microbiologists. All key decisions involved senior clinicians active at QECH. Local antimicrobial susceptibility trends, antibiotic availability and national guidelines were reviewed and used to design a consensus based antibiotic guideline which was reviewed by all senior clinicians in the departments. In Malawi, the burden of severe bacterial infection is high and it is critical that AMS does not restrict access to potentially lifesaving therapy [19] . Our guideline therefore focused on the importance of recognizing and treating sepsis and on 48-hour antibiotic step down.
The guideline was distributed using booklets, posters and as a smartphone antibiotic application, Microguide (http://www.microguide.eu/). Microguide allows prescribers to access hospital-specific guidelines on their mobile devices or hospital intranet. The QECH version can be viewed at https://viewer.microguide.global/QECH/ADULT4.
Point-prevalence surveys
An average of two to three PPS were carried out/month. Two numerators were defined in each survey: number of patients on ceftriaxone and number of patients on at least one antibiotic. All adult medical inpatients whose notes were available at the time of the survey were included and results from each PPS were presented to Department of Medicine meetings the following day. These meetings are compulsory for all cadres of clinicians and medical students working within the department.
Results were presented verbally by a study doctor who was clinically active on the medical wards. Attendees were informed what proportion of their patients were on ceftriaxone and what proportion were on at least one antibiotic and given a reminder to review their prescriptions.
Qualitative methods
Semi-structured interviews and observations with clinicians were carried out throughout the study (Supplementary Methods). Interviewees were purposively sampled based on their role in prescribing antibiotics and observations were conducted on medical ward rounds and in morning meetings. Transcripts and field notes were imported into Nvivo software package (QSR International Pty Ltd., version 11, 2015) and a thematic analysis was conducted.
Cost analysis
We explored the impact of the stewardship intervention on the direct health-provider costs of supplying antibiotics at QECH. First, we used data captured in the three prescribing surveys to estimate the total cost of all antibiotics given to participants in each survey. We divided this total cost by the total number of participants in each of the three surveys to estimate the average cost/participant. Secondly, we modelled how the stewardship intervention would impact on the mean cost/patient and the total annual cost of providing antibiotics to those admitted to the three medical wards (male medical; female medical; TB ward). We also estimated the annual cost of implementing the intervention (Supplementary Table 2 ).
Statistical analysis
Stewardship indicators from antibiotic surveys were described as proportions, and comparisons between pre -and post-implementation groups done using the  2 test.
Confidence intervals were calculated using the Wilson method. Assuming that errors would be approximately normally distributed, a linear regression model was used to detect linear trends in the prevalence of ceftriaxone and all-antibiotic prescriptions over time. Seasonality was adjusted for using harmonic terms with a one-year period.
For the PPS, data were recorded as missing if a patient file was not available at the time the survey was carried out. We assumed that missing records were missing at random and therefore not likely to bias the prevalence estimates. Data were analyzed using the R statistical package version 3.6.0 (R Foundation for Statistical Computing, Vienna, Austria).
Ethics
The study was approved by the Research Ethics 
RESULTS
The records of 203 patients were reviewed in the pre-implementation survey (Survey 1). One hundred records were reviewed in the first post-implementation survey (Survey 2) and 200 in the second (Survey 3). Table 3 ).
Clinically suspected focus of infection, as recorded in the medical notes, was similar across all surveys (Supplementary Results, Figure 1 ). Respiratory or central nervous system (CNS) infections were the most common syndromes recorded by admitting teams, whilst non-focal infection accounted for over 10% of recorded diagnoses.
Across the three surveys, proportion of records in which a suspected focus of infection was not recorded prior to antibiotic administration fell, from 15.3% (Survey 1) to 6% (Surveys 2 and 3).
A reduction in 3GC usage was seen after implementation of the stewardship program, as measured by pre and post-implementation antibiotic surveys ( Figure 1 , Table 2 ), antibiotic PPS ( Figure 2 ) and median duration of antibiotic prescription ( Figure 1 , Table 2 ).
The proportion of all antibiotic prescriptions for an intravenous 3GC fell from 193/241 (80.1%) to 177/330 (53.6%) (percentage decrease 26.5% [95%CI; 18.7 to
34.1])
between the first and last surveys and the median length of ceftriaxone course reduced from five to four days ( Table 2 ). This paralleled an increase in clinician 48- Table 4 .
The median number of charts included in each PPS was 100 (IQR 94-101). A median of 2 files (IQR 2-4) were recorded as missing in each survey. In the first PPS, 78% of patients on the ward were receiving ceftriaxone and 86% were receiving at least one antibiotic of any class. Figure 2 shows the results of 71 PPS carried out over a period of 28-months and a decline in ceftriaxone prescriptions over the study period (p<0.01). Although Table 2 shows an increase in ciprofloxacin and metronidazole prescriptions across the three prescribing surveys, there was no evidence of a linear trend in all-antibiotic prevalence over time (p = 0.15) ( Figure 2 ). The coefficients of the harmonic terms in the regression model, Table 5 ). Table 3 shows the mean cost/patient and total cost estimated from modelling the impact of the stewardship program across the three adult medical wards at QECH. The mean cost per patient and total costs were lower on the TB ward as many patients are admitted to this ward to receive the initial phase of TB treatment and the cost of anti-TB drugs were not included here. At patient level, the mean cost across the three adult medical wards is projected to fall from US$6.79 per patient, to US$5.23 per patient. The total annual cost of providing antibiotics to these three wards is projected to fall from US$67,058.14 to US$51,566.60. The total annual cost of delivering the intervention was US$4,358.78 (Supplementary Methods).
Two rounds of semi-structured interviews were conducted: 20 in the preimplementation period and 21 in the post-implementation period. Due to high turnover of junior level doctors on the medical wards, only one participant was interviewed before and after the guideline introduction. Characteristics of interviewees are summarized in Supplementary Results, Table 6 . Analysis of qualitative data identified six key themes relating to the stewardship intervention: facilitators (accessibility of information, trust in guideline content, awareness) and barriers (operational barriers, hierarchical relationships and rationalized overprescribing). Themes are summarized below and key quotes are presented in Table 4 .
Facilitators Theme 1: Accessibility of information
The majority of participants in the post-implementation period reported use of the guideline (quotes 1.1 -1.2) and regular consultation of Microguide was observed during ward rounds. This was in marked contrast to the pre-implementation interviews, in which participants cited a range of resources to guide prescribing and difficulty in finding locally relevant information (quotes 1.3 -1.4). Junior level doctors in particular, perceived that they now had a new resource which would guide them towards narrow-spectrum antibiotics, and valued the ability to access the guideline on their smartphones (quote 1.5).
Theme 2: Trust in the guideline content
Most participants felt invested in the guideline, noting the department's involvement in its inception and development (quotes 2.1-2.2). The locally appropriate nature of the guidance was cited as crucial in almost all post-implementation interviews, in particular with regard to antibiotic availability and pathogen (quotes 2.2-2.4).
Theme 3: Awareness and promotion of stewardship and AMR
The process surrounding introduction of the stewardship intervention was perceived to raise awareness of AMR and of overprescribing within the department. Physicians of all cadres reported thinking more about their antibiotic prescribing practices than before the intervention (quotes 3.1-3.2).
Barriers
Multiple routes to ceftriaxone overprescribing were identified in the thematic analysis in the pre-and post-implementation phase. 
DISCUSSION
We demonstrate that antimicrobial stewardship is feasible and effective in a lowincome country, in a hospital which has no specialist clinical microbiology or wardlevel pharmacy service, a limited antibiotic formulary and no previous ethos of stewardship. A locally appropriate, pragmatic antibiotic guideline using smartphone technology, supported by a simple educational strategy of weekly 'reminders' led to a significant reduction in 3GC usage, an increase in the proportion of 48-hour antibiotic reviews and a cost-saving of over US$15,000 for the medical wards. Critically, case fatality rate did not change in the pre-and post-implementation surveys, nor on the medical wards in general during the study period. This study has several limitations. Although the PPS show a significant decline in prevalence of ceftriaxone usage over the study period, we have limited data from the pre-implementation phase. However, previous studies at QECH prior to the intervention, have shown ceftriaxone prescribing prevalence of 70-84% [19, 30] , consistent with our pre-implementation findings. Further, we did not engage with an implementation science framework to guide the design of this first-stage qualitative study, which would be a necessary component of a scale up. We have implemented an AMS program on adult wards, but pediatric and community level antibiotic usage are likely to be major drivers of antibiotic consumption and thus AMR [31]. Largescale stewardship must target these settings next.
We have demonstrated the sustainability of the AMS program over a 28-month period, but measuring its long-term impact, whilst essential, is outside the scope of this study. The potential cost-saving achieved by the reduction in antibiotic usage is key to the sustainability of our program and an antibiotic pharmacist could continue the regular PPS. Involving clinical departments and hospital management in guideline development is fundamental to its sustainability. Our guideline is integrated into departmental teaching and the Microguide app. provides a function for real-time feedback from prescribers, allowing regular updates to be incorporated as often as Let's say there's amoxicillin, but I'd want to give something slightly more broad spectrum, like augmentin. But there isn't. And probably the next best thing is ceftriaxone. So sometimes you use an antibiotic which you didn't necesSArily want to use One of them is because the oral drug is out of stock, so the only choice I had was to give a broad spectrum that was IV, but if I had a chance I would have given an oral antibiotic. It has happened so many times, not once.
For example there should be commitment from management to ensure that even simpler antibiotics should be made readily available because even if broad spectrum antibiotics only are available and patient has come in with simple community acquired pneumonia, people may be tempted to use broad spectrum antibiotic, because they are only what is available. So, I think there should be a commitment from the management team to ensure that more antibiotics are available All the (non-infective) neurological cases viewed this morning had an infective differential. All of these patients had HIV so this is not just speculation, it's a real risk. Insufficiency of neuro-imaging means that the infective cause cannot be ruled out until we get an MRI or the LP or blood culture results get backall of which will be 5 days When I arrived in 2009, the numbers of patients on our wards was really horrendous…so there will be one on the bed, one on the floor, all the way into the corridors. So if you had two trained nurses per shift it meant that they would be sitting at their desk drawing the antibiotics the whole day. …….if they were to do that four times a day they did nothing else. So ..patients stared getting maybe one dose, or 2 doses…..but never 4 doses. So we sort of like just slowly drifted towards ..once daily antibiotics, ceftriaxone.
Hierarchical relationships and prescribing practice
Observation, Postimplementation Medical student, Preimplementation Registrar, Preimplementation 5.1 5.2
5.3
There is a palpable power dynamic on this ward round. … Consultant says out loud we should stop ceftriaxone and wrote 'CSF normal, stop ceftriaxone'. He did not look at the drug chart and did not cross ceftriaxone off. No-on else on ward round crossed off …and we moved on to the next patient. Certainly, ward round participants don't seem keen to speak unless directly addressed, maybe they don't want to cause disruption to the ward round by stopping to cross off antibiotic.
But as students when you see the files and you see people prescribe amoxicillin, ceftriaxone, you think that's the way to go because we see people practicing it, but then sometimes when you're on ward round you see a consultant prescribing an antibiotic which you never know is here… I think the interns who come to the department, they see most of the time people are on ceftriaxone, so when they are stuck, they will think that maybe by giving that, they will be off the hook.
Rationalized overprescribing
Registrar, Preimplementation
Consultant, Post-Intervention
Consultant, Postintervention 6.1 6.2
6.3
That could be one possibility, because if I am certain you can just give an antibiotic which you feel is safe…
And when the patients are perceived to be quite unwell, that's where the problem of sticking to the guidelines seems to be an issue….
It basically makes people not to think because they have a knee jerk reaction to everyone who has a fever, to give them ceftriaxone without thinking as to where the focus of infection is, so that you can choose an appropriate antibiotic for the focus of infection. So everyone just gives ceftriaxone as a fall-back position. So it stops people thinking about what is their ideal treatment in this setting. 
